HLA-C and neoplasm: Unlike CAR-T cells that have receptors targeting naturally occurring antigens, TCR-T cells are engineered to express a transgenic T cell receptor specific for a tumor-associated antigen formed only from the complex of a tumor peptide and an MHC molecule [76].